Cargando…

Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis Scoring

Background and objective: Pre-existing interstitial lung disease (ILD) in lung cancer patients is considered a risk factor for anti-cancer drug-induced pneumonia; however, a method for evaluating ILD, including mild cases, has not yet been established. We aimed to elucidate whether the quantitative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gyotoku, Hiroshi, Yamaguchi, Hiroyuki, Ishimoto, Hiroshi, Sato, Shuntaro, Taniguchi, Hirokazu, Senju, Hiroaki, Kakugawa, Tomoyuki, Nakatomi, Katsumi, Sakamoto, Noriho, Fukuda, Minoru, Obase, Yasushi, Soda, Hiroshi, Ashizawa, Kazuto, Mukae, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230276/ https://www.ncbi.nlm.nih.gov/pubmed/32272762 http://dx.doi.org/10.3390/jcm9041045

Ejemplares similares

Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer
por: Taniguchi, Hirokazu, et al.
Publicado: (2019)

Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non‐squamous non‐small cell lung cancer
por: Takemoto, Shinnosuke, et al.
Publicado: (2017)

Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets
por: Shimada, Midori, et al.
Publicado: (2023)

Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the BRAF V600E mutation
por: Dotsu, Yosuke, et al.
Publicado: (2020)

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor
por: Dotsu, Yosuke, et al.
Publicado: (2021)

Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study
por: Takemoto, Shinnosuke, et al.
Publicado: (2019)

Postoperative acute exacerbation of interstitial pneumonia in pulmonary and non-pulmonary surgery: a retrospective study
por: Miyamura, Takuto, et al.
Publicado: (2019)

Pulmonary Alveolar Proteinosis with Ulcerative Colitis
por: Sakamoto, Noriho, et al.
Publicado: (2018)

Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis
por: Kakugawa, Tomoyuki, et al.
Publicado: (2016)

Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis
por: Takemoto, Shinnosuke, et al.
Publicado: (2021)

Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanoma
por: Ikeda, Takaya, et al.
Publicado: (2018)

Autoimmune pulmonary alveolar proteinosis exacerbated by steroid therapy due to misdiagnosis as anti-aminoacyl-tRNA synthetase (ARS) antibody positive- interstitial pneumonia: a case report
por: Ishimoto, Hiroshi, et al.
Publicado: (2022)

Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
por: Ikeda, Takaya, et al.
Publicado: (2020)

Presence of heat shock protein 47-positive fibroblasts in cancer stroma is associated with increased risk of postoperative recurrence in patients with lung cancer
por: Miyamura, Takuto, et al.
Publicado: (2020)

Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction
por: Shimada, Midori, et al.
Publicado: (2017)

Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan‐related toxicities in patients with lung cancer
por: Fukuda, Minoru, et al.
Publicado: (2017)

Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study
por: Tomono, Hiromi, et al.
Publicado: (2023)

Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease
por: Sakamoto, Noriho, et al.
Publicado: (2018)

Remarkable response to pembrolizumab with platinum‐doublet in PD‐L1‐low pulmonary sarcomatoid carcinoma: A case report
por: Taniguchi, Hirokazu, et al.
Publicado: (2021)

The acoustic characteristics of fine crackles predict honeycombing on high-resolution computed tomography
por: Fukumitsu, Toshikazu, et al.
Publicado: (2019)

Interstitial Pneumonia with HLA-B54 Antigen that Responded Well to Erythromycin
por: Ishimoto, Hiroshi, et al.
Publicado: (2022)

Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
por: Sakamoto, Noriho, et al.
Publicado: (2015)

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study
por: Akagi, Kazumasa, et al.
Publicado: (2022)

Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
por: Sakamoto, Noriho, et al.
Publicado: (2018)

Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy
por: Takemoto, Shinnosuke, et al.
Publicado: (2023)

Idiopathic desquamative interstitial pneumonia diagnosed using transbronchial lung cryobiopsy: A case report
por: Ishimoto, Hiroshi, et al.
Publicado: (2021)

Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA
por: Takemoto, Shinnosuke, et al.
Publicado: (2019)

Removal of an aspirated tooth from the bronchus using a cryoprobe: A case report
por: Ishimoto, Hiroshi, et al.
Publicado: (2021)

Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
por: Umeyama, Yasuhiro, et al.
Publicado: (2023)

Remarkable response of nivolumab‐refractory lung cancer to salvage chemotherapy
por: Ogawara, Daiki, et al.
Publicado: (2017)

Hypertrophic osteoarthropathy associated with lung cancer: Possible links among hypoxia‐inducible factor‐1α, vascular endothelial growth factor, and hypervascularization
por: Tagawa, Ryuta, et al.
Publicado: (2023)

Pneumoconiosis with a Sarcoid-Like Reaction Other than Beryllium Exposure: A Case Report and Literature Review
por: Hayashi, Fumiko, et al.
Publicado: (2020)

Pulmonary Langerhans Cell Histiocytosis That Progressed from a Single-system to a Multisystem Form despite Smoking Cessation
por: Ishimoto, Hiroshi, et al.
Publicado: (2022)

HSP47: A Therapeutic Target in Pulmonary Fibrosis
por: Sakamoto, Noriho, et al.
Publicado: (2023)

Pulmonary and Intestinal Involvement in a Patient with Myeloperoxidase-specific Antineutrophil Cytoplasmic Antibody-positive Hermansky-Pudlak Syndrome
por: Tokito, Takatomo, et al.
Publicado: (2022)

Alert Regarding Cisplatin-induced Severe Adverse Events in Cancer Patients with Xeroderma Pigmentosum
por: Sumiyoshi, Makoto, et al.
Publicado: (2017)

Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy
por: Senju, Hiroaki, et al.
Publicado: (2018)

Pulmonary Langerhans cell histiocytosis diagnosed using transbronchial lung cryobiopsy: A case report()
por: Mine, Keisuke, et al.
Publicado: (2023)

Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases
por: Ogata, Ryosuke, et al.
Publicado: (2022)

Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
por: Kakugawa, Tomoyuki, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_p7btlvm7korioo0j8isrs6kjs3